| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |